Cuizhen Xiao

This inventor holds 1 USPTO granted patent. Top assignee: Bio-Thera Solutions, Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cuizhen Xiao. Retrieved from https://idiyas.com/inventor/cuizhen-xiao-yr37d0w2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cuizhen Xiao: Innovator in Antibody Development

Introduction

Cuizhen Xiao is a prominent inventor known for his contributions to the field of biotechnology. He has made significant strides in the development of recombinant antibodies, which are crucial for various therapeutic applications. His innovative work has garnered attention in the scientific community.

Latest Patents

Cuizhen Xiao holds a patent titled "Recombinant Antibody Having Unique Glycan Profile Produced by CHO Host Cell with Edited Genome and Preparation Method Thereof." This patent highlights his expertise in creating antibodies with unique glycan profiles, which can enhance their efficacy in medical treatments. He has 1 patent to his name, showcasing his commitment to advancing biopharmaceutical technologies.

Career Highlights

Xiao is currently employed at Bio-Thera Solutions, Ltd., a company dedicated to developing innovative biopharmaceutical products. His role at the company allows him to apply his knowledge and skills in antibody engineering, contributing to the advancement of therapeutic solutions.

Collaborations

Cuizhen Xiao has collaborated with notable colleagues, including Chao Qin and Yuanqing Zhou. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Cuizhen Xiao's work in antibody development exemplifies the impact of innovation in biotechnology. His contributions are paving the way for new therapeutic options and enhancing the understanding of antibody engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…